CA2520512A1 - Methods, compositions and kits for the detection and monitoring of lung cancer - Google Patents

Methods, compositions and kits for the detection and monitoring of lung cancer Download PDF

Info

Publication number
CA2520512A1
CA2520512A1 CA002520512A CA2520512A CA2520512A1 CA 2520512 A1 CA2520512 A1 CA 2520512A1 CA 002520512 A CA002520512 A CA 002520512A CA 2520512 A CA2520512 A CA 2520512A CA 2520512 A1 CA2520512 A1 CA 2520512A1
Authority
CA
Canada
Prior art keywords
lys
ser
leu
ala
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002520512A
Other languages
English (en)
French (fr)
Inventor
Barbara K. Zehentner-Wilkinson
Dawn C. J. Hayes
Raymond L. Houghton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2520512A1 publication Critical patent/CA2520512A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002520512A 2003-03-24 2004-03-10 Methods, compositions and kits for the detection and monitoring of lung cancer Abandoned CA2520512A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45726103P 2003-03-24 2003-03-24
US60/457,261 2003-03-24
US50299503P 2003-09-15 2003-09-15
US60/502,995 2003-09-15
PCT/US2004/007451 WO2004084804A2 (en) 2003-03-24 2004-03-10 Detection and monitoring of lung cancer

Publications (1)

Publication Number Publication Date
CA2520512A1 true CA2520512A1 (en) 2004-10-07

Family

ID=33101281

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002520512A Abandoned CA2520512A1 (en) 2003-03-24 2004-03-10 Methods, compositions and kits for the detection and monitoring of lung cancer

Country Status (6)

Country Link
US (1) US20070042368A1 (enExample)
EP (1) EP1606303A4 (enExample)
JP (1) JP2006521110A (enExample)
AU (1) AU2004224448A1 (enExample)
CA (1) CA2520512A1 (enExample)
WO (1) WO2004084804A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004077021A2 (en) * 2003-02-27 2004-09-10 Lesko Stephen A Standardized evaluation of therapeutic efficacy based on cellular biomarkers
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
HUE031848T2 (en) 2008-09-20 2017-08-28 Univ Leland Stanford Junior Non-invasive diagnosis of fetal aneuploidy by sequencing
WO2024026284A2 (en) * 2022-07-25 2024-02-01 Interius Biotherapeutics, Inc. Mutated polypeptides, compositions comprising the same, and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US660833A (en) * 1900-05-22 1900-10-30 Harry W Bell Partition.
US5795723A (en) * 1994-05-06 1998-08-18 Fred Hutchinson Cancer Research Center Expression of neurogenic bHLH genes in primitive neuroectodermal tumors
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6518256B1 (en) * 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) * 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) * 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) * 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6210883B1 (en) * 1998-03-18 2001-04-03 Corixa Corporation Compounds and methods for diagnosis of lung cancer
US6821518B1 (en) * 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
US20030125245A1 (en) * 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6686447B1 (en) * 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1366157A2 (en) * 2000-06-29 2003-12-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1343886A2 (en) * 2000-07-11 2003-09-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2002309583A1 (en) * 2001-04-18 2002-11-05 Protein Desing Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US20030103994A1 (en) * 2001-06-28 2003-06-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
JP2006521110A (ja) 2006-09-21
EP1606303A4 (en) 2007-11-21
WO2004084804A2 (en) 2004-10-07
EP1606303A2 (en) 2005-12-21
US20070042368A1 (en) 2007-02-22
AU2004224448A1 (en) 2004-10-07
WO2004084804A3 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
EP1272668B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
CN109790583B (zh) 对肺腺癌亚型分型的方法
RU2721916C2 (ru) Способы прогнозирования рака предстательной железы
CN109863251B (zh) 对肺鳞状细胞癌亚型分型的方法
DK2681333T3 (en) EVALUATION OF RESPONSE TO GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASIS (GEP-NENE) THERAPY
AU2014295980B2 (en) Methods for the detection and treatment of leukemias that are responsive to DOT1L inhibition
KR20140006898A (ko) 결장암 유전자 발현 시그니처 및 이용 방법
KR20190026769A (ko) 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
US20030170631A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
CN109423515B (zh) 一组用于肝癌检测的基因标志物及其应用
AU2020201779B2 (en) Method for using gene expression to determine prognosis of prostate cancer
CA2520512A1 (en) Methods, compositions and kits for the detection and monitoring of lung cancer
KR102555330B1 (ko) SARS-CoV-2 진단용 조성물, 키트 및 이를 이용한 SARS-CoV-2의 진단방법
WO2014036444A1 (en) Prame detection assays
US20030175761A1 (en) Identification of genes whose expression patterns distinguish benign lymphoid tissue and mantle cell, follicular, and small lymphocytic lymphoma
CN108779496B (zh) 罹患食管基底细胞样鳞状细胞癌的鉴别方法
US20030175704A1 (en) Genes expressed in lung cancer
EP2066810A2 (en) Methods, compositions, and kits for the detection and monitoring of colon cancer
WO2007114954A2 (en) Methods, compositions, and kits for the detection and monitoring of kidney cancer
EP1660676B1 (en) Diagnosis of risk of breast cancer
US20060292600A1 (en) Methods, compositions and kits for the detection and monitoring of lung cancer
HK40081979A (en) Composition for diagnosing sars-cov-2, kit, and method for diagnosing sars-cov-2 by using same
WO2005111245A1 (en) Progesterone receptor transcript sequences
TW201015069A (en) Markers for detection of gastric cancer
ZA200409420B (en) Methods and compositions for diagnosing and monitoring transplant rejection

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued